These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 33879073)

  • 41. Early clinical factors predicting the development of critical disease in Japanese patients with COVID-19: A single-center, retrospective, observational study.
    Higuchi T; Nishida T; Iwahashi H; Morimura O; Otani Y; Okauchi Y; Yokoe M; Suzuki N; Inada M; Abe K
    J Med Virol; 2021 Apr; 93(4):2141-2148. PubMed ID: 33090527
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Survival Evaluation of Hospitalized COVID-19 Patients with Cox Frailty Approach.
    Osmani F; Ziaee M
    Disaster Med Public Health Prep; 2022 Aug; 17():e233. PubMed ID: 35979746
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CT-Based Risk Factors for Mortality of Patients With COVID-19 Pneumonia in Wuhan, China: A Retrospective Study.
    Li X; Li N; Chen Z; Ye L; Zhang L; Jin D; Gao L; Liu X; Lai B; Yao J; Guo D; Zhang H; Lu L; Xiao J; Huang L; Ai F; Wang X
    Front Radiol; 2021; 1():661237. PubMed ID: 37492171
    [No Abstract]   [Full Text] [Related]  

  • 44. New Scoring System for Predicting Mortality in Patients with COVID-19.
    Bae S; Kim Y; Hwang S; Kwon KT; Chang HH; Kim SW
    Yonsei Med J; 2021 Sep; 62(9):806-813. PubMed ID: 34427066
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Assessment of Clinical Indicators Registered on Admission to the Hospital Related to Mortality Risk in Cancer Patients with COVID-19.
    Szewczyk-Dąbrowska A; Banasik M; Dąbrowska K; Kujawa K; Bombala W; Sebastian A; Matera-Witkiewicz A; Krupińska M; Grata-Borkowska U; Sokołowski J; Kiliś-Pstrusińska K; Adamik B; Doroszko A; Kaliszewski K; Pomorski M; Protasiewicz M; Jankowska EA; Madziarska K
    J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Laboratory Findings in Different Disease Status of COVID-19 Admitted Patients at Dilla University Referral Hospital Treatment Center, South Ethiopia.
    Churiso G; Diriba K; Girma H; Tafere S
    Infect Drug Resist; 2022; 15():4307-4320. PubMed ID: 35965852
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Effect of Host miRNAs on Prognosis in COVID-19: miRNA-155 May Promote Severity via Targeting Suppressor of Cytokine Signaling 1 (
    Gedikbasi A; Adas G; Isiksacan N; Kart Yasar K; Canbolat Unlu E; Yilmaz R; Hergunsel GO; Cukurova Z
    Genes (Basel); 2022 Jun; 13(7):. PubMed ID: 35885930
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Coronary artery calcification on low-dose chest CT is an early predictor of severe progression of COVID-19-A multi-center, multi-vendor study.
    Fervers P; Kottlors J; Große Hokamp N; Bremm J; Maintz D; Tritt S; Safarov O; Persigehl T; Vollmar N; Bansmann PM; Abdullayev N
    PLoS One; 2021; 16(7):e0255045. PubMed ID: 34288966
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Involvement of Chronic Kidney Disease and Acute Kidney Injury in Disease Severity and Mortality in Patients with COVID-19: A Meta-Analysis.
    Wang B; Luo Q; Zhang W; Yu S; Cheng X; Wang L; Chen X; Chen Y
    Kidney Blood Press Res; 2021; 46(1):17-30. PubMed ID: 33352576
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Dynamic changes of D-dimer and neutrophil-lymphocyte count ratio as prognostic biomarkers in COVID-19.
    Ye W; Chen G; Li X; Lan X; Ji C; Hou M; Zhang D; Zeng G; Wang Y; Xu C; Lu W; Cui R; Cai Y; Huang H; Yang L
    Respir Res; 2020 Jul; 21(1):169. PubMed ID: 32620118
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The characteristics of laboratory tests at admission and the risk factors for adverse clinical outcomes of severe and critical COVID-19 patients.
    Wang L; Cheng X; Dong Q; Zhou C; Wang Y; Song B; Li W; Wang M; Qin R; Long Q; Liu J; Li J; Li D; Li G; Ba Y
    BMC Infect Dis; 2021 Apr; 21(1):371. PubMed ID: 33879073
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study.
    Xu PP; Tian RH; Luo S; Zu ZY; Fan B; Wang XM; Xu K; Wang JT; Zhu J; Shi JC; Chen F; Wan B; Yan ZH; Wang RP; Chen W; Fan WH; Zhang C; Lu MJ; Sun ZY; Zhou CS; Zhang LN; Xia F; Qi L; Zhang W; Zhong J; Liu XX; Zhang QR; Lu GM; Zhang LJ
    Theranostics; 2020; 10(14):6372-6383. PubMed ID: 32483458
    [No Abstract]   [Full Text] [Related]  

  • 53. Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.
    Shi Q; Zhang X; Jiang F; Zhang X; Hu N; Bimu C; Feng J; Yan S; Guan Y; Xu D; He G; Chen C; Xiong X; Liu L; Li H; Tao J; Peng Z; Wang W
    Diabetes Care; 2020 Jul; 43(7):1382-1391. PubMed ID: 32409504
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors for disease progression in patients with mild to moderate coronavirus disease 2019-a multi-centre observational study.
    Cen Y; Chen X; Shen Y; Zhang XH; Lei Y; Xu C; Jiang WR; Xu HT; Chen Y; Zhu J; Zhang LL; Liu YH
    Clin Microbiol Infect; 2020 Sep; 26(9):1242-1247. PubMed ID: 32526275
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of risk factors for in-hospital death of COVID - 19 pneumonia -- lessions from the early outbreak.
    Wang Z; Wang Z
    BMC Infect Dis; 2021 Jan; 21(1):113. PubMed ID: 33494706
    [TBL] [Abstract][Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.